Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...
New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...
Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS ...
UTs did not submit NSQ data to Centre in December: Gireesh Babu, New Delhi Tuesday, January 28, 2025, 08:00 Hrs [IST] Even as the reporting of Not of Standard Qual ...
In May 2024, Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited (formerly Cadila Healthcare) announced the conclusion of their joint venture, Bayer Zydus Pharma Private Limited.
Its clients include leading pharmaceutical companies like Aurobindo Pharma, Cadila Pharmaceuticals, Granules India Ltd, Macleods Pharmaceuticals, Piramal Pharma, and Suven Pharmaceuticals.
Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...
Its pharma clients include Aurobindo Pharma, Cadila Pharmaceutical, Granules India Ltd, Macleods Pharmaceuticals, Piramal Pharma, and Suven Pharmaceuticals. IIFL Capital Services Ltd (formerly ...
Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2024, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 975.80. On previous ...
Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed ...
Standard Glass Lining Technology Ltd's IPO was oversubscribed by 182.57 times, with strong demand from QIBs, non-institutional investors, and retail investors. The IPO raised Rs 410.05 crore.